dendritic cell prostate tumor vaccine (ODC)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namedendritic cell prostate tumor vaccine (ODC)

Drug Alias NameODC-0601

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesOdc Therapy

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOdc Therapy

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A